Beyond the Hype: Unveiling the Real Impact of Generative AI in Drug Discovery
Unite.AI
SEPTEMBER 23, 2024
Since Insilico Medicine developed a drug for idiopathic pulmonary fibrosis (IPF) using generative AI, there's been a growing excitement about how this technology could change drug discovery. Traditional methods are slow and expensive , so the idea that AI could speed things up has caught the attention of the pharmaceutical industry. Startups are emerging, looking to make processes like predicting molecular structures and simulating biological systems more efficient.
Let's personalize your content